BioSpace News Archive

Teewinot Life Sciences and its wholly owned Irish subsidiary Teewinot Technologies announced today the grant of U.S. Patent No. 9,861,609.

IONTAS Limited, a leader in the discovery and optimisation of fully human antibodies, announced today that it has signed an agreement with Sanofi to discover antibodies using IONTAS’ proprietary Mammalian Display Technology.

The transaction is comprised of approximately $190M of cash proceeds at closing plus up to approximately $40M in milestone payments.

Braeburn’s receipt of a CRL from the FDA regarding the NDA for its injectable buprenorphine product is likely to negatively impact Braeburn’s Probuphine marketing activities as it focuses on addressing the CRL.

PositiveID and ExcitePCR have published the report on their websites.

This Phase 1/2 clinical trial launched in December 2017 and enrollment into the first cohort has been rapidly completed.

The American Society for Parenteral and Enteral Nutrition (ASPEN) and Fresenius Kabi announced today a new educational video series highlighting best practices for dosing, preparing and administering intravenous lipid emulsions (ILE).

J&J Vision today announced the U.S. launch of expanded parameters for 1-DAY ACUVUE MOIST Brand Contact Lenses for ASTIGMATISM, a daily disposable contact lens that offers patients BLINK-STABILIZED Design for clear, stable vision and LACREON Technology that provides a cushion of moisture for long-lasting comfort.

The JV represents a global first in a collaboration to produce comprehensive precision pharmaceutical grade medicine, derived from medical botanicals.

This patent consolidates BioAxial’s patent portfolio, which already comprises ten patent families.